BioPharmX
Menlo Park, US · Founded 2014 · Delaware corporation
Biotech
Founders & leadership
AK
Anja KrammerPresident and Director
GK
Greg KitchenerChief Financial Officer
MH
Michael HubbardChairman
SM
Stephen MorlockDirector
Reported raises · per SEC filings
Form D private placements▶Undisclosed amountofferedOct 2022 · 2 investors · PharmaceuticalsRule 506(b)
▶Undisclosed amountofferedOct 2022 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LuccheseExecutive Officer
- Alan M. MendelsohnExecutive Officer
- Edward J. SitarDirector
- David E. CohenDirector
- Lubor GaalDirector
- John KoconisExecutive Officer, Director
- Gianluca PirozziDirector
- Placement agents
- H.C. Wainwright & Co. LLC
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$930KraisedOct 2016 · 5 investors · PharmaceuticalsRule 506(b)
▶$930KraisedOct 2016 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Greg KitchenerExecutive Officer
- Anja KrammerExecutive Officer, Director
- Michael HubbardDirector
- Stephen MorlockDirector
- Offering amount
- $930K
- Amount sold
- $930K
- Sales commissions
- $55.8K
- Placement agents
- Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$508.5KraisedMar 2015 · 1 investors · PharmaceuticalsRule 506(b)
▶$508.5KraisedMar 2015 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anja KrammerExecutive Officer, Director
- Kin ChanExecutive Officer
- Michael HubbardDirector
- Ping WangDirector
- James PekarskyExecutive Officer, Director
- Offering amount
- $508.5K
- Amount sold
- $508.5K
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$7.9MraisedMar 2015 · 51 investors · PharmaceuticalsRule 506(b)
▶$7.9MraisedMar 2015 · 51 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- JAMES PEKARSKYExecutive Officer, Director
- PING WANGDirector
- ANJA KRAMMERExecutive Officer, Director
- KIN CHANExecutive Officer
- MICHAEL HUBBARDDirector
- Offering amount
- $18.6M
- Amount sold
- $7.9M
- Finders' fees
- $227.2K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$134.3KraisedMar 2015 · 16 investors · Pharmaceuticals
▶$134.3KraisedMar 2015 · 16 investors · Pharmaceuticals
Officers, directors & promoters on the filing
- James PekarskyExecutive Officer, Director
- Kin ChanExecutive Officer
- Ping WangDirector
- Anja KrammerExecutive Officer, Director
- Michael HubbardDirector
- Offering amount
- $134.3K
- Amount sold
- $134.3K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 05
▶$1.8MraisedMar 2015 · 25 investors · PharmaceuticalsRule 506(b)
▶$1.8MraisedMar 2015 · 25 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ping WangDirector
- James PekarskyExecutive Officer, Director
- Anja KrammerExecutive Officer, Director
- Michael HubbardDirector
- Kin ChanExecutive Officer
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Aug 2012
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.